Eli Lilly & Co |
9.59% |
Novo Nordisk A/S |
6.96% |
UnitedHealth Group Inc |
6.81% |
AbbVie Inc |
5.53% |
Thermo Fisher Scientific Inc |
4.93% |
AstraZeneca PLC |
4.54% |
Intuitive Surgical Inc |
3.92% |
Danaher Corp |
3.78% |
Boston Scientific Corp |
3.56% |
Roche Holding AG |
3.48% |
Johnson & Johnson |
3.43% |
Stryker Corp |
3.37% |
Sanofi |
3.23% |
Zoetis Inc |
3.12% |
Merck & Co Inc |
2.59% |
Vertex Pharmaceuticals Inc |
2.57% |
Bristol-Myers Squibb Co |
2.41% |
CSL Ltd |
2.07% |
McKesson Corp |
2.07% |
Alcon Inc |
2.02% |
Cooper Cos Inc |
2.00% |
Neurocrine Biosciences Inc |
1.78% |
SPDR S&P Biotech ETF |
1.77% |
Lonza Group AG |
1.30% |
Centene Corp |
1.24% |
IDEXX Laboratories Inc |
1.04% |
Pfizer Inc |
0.96% |
Royalty Pharma PLC |
0.93% |
Align Technology Inc |
0.89% |
Mettler-Toledo International Inc |
0.88% |
Zimmer Biomet Holdings Inc |
0.88% |
Amplifon SpA |
0.86% |
Sartorius AG |
0.83% |
ARGENX SE - ADR |
0.83% |
Teleflex Inc |
0.79% |
Straumann Holding AG |
0.75% |
Neogen Corp |
0.64% |
AptarGroup Inc |
0.62% |
Asahi Intecc Co Ltd |
0.43% |
iShares Global Healthcare ETF |
0.25% |
JMDC Inc |
0.19% |
CARIS LIFE SCIENCES, INC |
0.05% |
DANISH KRONE |
0.00% |
MSILF GOVERNMENT PORTFOLIO MSILF GOVERNMENT PORTFOLIO |
0.00% |